Risk of Impairment and Valuation Losses on Held Securities Due to Falling Share Prices
First written in FY2016. 19 of 26 entries say "Restated". Latest entry: FY2026.
The whole theme swung hardest in 2019: 64 of 141 companies on the "Worse" side.
57 other companies' latest entry also says "Mitigated".
- FY2026MitigatedAnnual report
「There were no applicable items during the fiscal year under review.」
The disclosure states that no impairment losses on securities were recognized during the current consolidated fiscal year, and does not confirm the realization of the valuation loss risk that arose through the previous fiscal year. - FY2024-Q3RestatedAnnual report
「During the nine-month period ended 31 December, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The company has reaffirmed that there have been no material changes regarding the risks associated with declines in the share prices and fluctuations in the valuations of securities held. - FY2024-Q1RestatedAnnual report
「No new business or other risks arose during the first three months of the fiscal year, and there were no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The company has reaffirmed that there have been no material changes regarding the risks associated with declines in the share prices and fluctuations in the valuations of securities held. - FY2023RestatedAnnual report
「Our group holds multiple listed and unlisted securities. Depending on stock market conditions and the operating results and financial position of investee companies, the valuation of securities held may fluctuate, potentially affecting our group's financial position and operating results.」
The company has reaffirmed the risk that the valuation of securities may fluctuate depending on stock market conditions and the operating results and financial position of investee companies. No impairment losses on securities were recognized during the current fiscal year. - FY2023-Q3RestatedAnnual report
「During the nine-month period ended 31 December, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The company has reaffirmed that there have been no material changes regarding the risk of impairment losses and valuation losses resulting from declines in the share prices of securities held. - FY2023-Q1RestatedAnnual report
「No new business or other risks arose during the first three months of the fiscal year, and there were no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The company has reaffirmed that there have been no material changes regarding the risk of impairment losses and valuation losses resulting from declines in the share prices of securities held. - FY2022ReframedAnnual report
「Our group holds multiple listed and unlisted securities. Depending on stock market conditions and the operating results and financial position of investee companies, the valuation of securities held may fluctuate, potentially affecting our group's financial position and operating results.」
The description changed from the previous risk of impairment losses and valuation losses due to a broad and significant decline in share prices to a broader description of the risk of fluctuations in the valuation of securities due to stock market conditions and the operating results and financial position of investee companies. The company's response of emphasizing factors such as PBR when selecting investments is also described. - FY2022-Q3RestatedAnnual report
「During the nine-month period ended 31 December, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The company has reaffirmed that there have been no material changes regarding the risk of impairment losses and valuation losses resulting from declines in the share prices of securities held. - FY2022-Q1RestatedAnnual report
「No new business or other risks arose during the first three months of the fiscal year, and there were no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The company has reaffirmed that there have been no material changes regarding the risk of impairment losses and valuation losses resulting from declines in the share prices of securities held. - FY2021MitigatedAnnual report
「There were no applicable items during the fiscal year under review.」
In contrast to the recognition of ¥205,842 thousand in impairment losses on securities in the previous fiscal year, no impairment losses on securities were recognized during the current consolidated fiscal year, and all other securities with a market value at the fiscal year-end exceeded their acquisition costs. - FY2021-Q3MitigatedAnnual report
「At the end of the third quarter of the current consolidated fiscal year, total assets were ¥24,403 million, an increase of ¥1,652 million from the end of the previous consolidated fiscal year. The main factors were the acquisition of investment securities and increases in their fair value.」
The acquisition of investment securities and increases in their fair value were cited as factors contributing to the increase in total assets, and the valuation of securities held for which valuation losses were recorded in the previous fiscal year was improving. - FY2021-Q2RestatedAnnual report
「No new business or other risks arose during the first six months of the fiscal year, and there were no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The company has reaffirmed that there have been no material changes regarding the risk of impairment losses and valuation losses resulting from declines in the share prices of securities held. - FY2021-Q1RestatedAnnual report
「No new business or other risks arose during the first three months of the fiscal year, and there were no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The company has reaffirmed that there have been no material changes regarding the risk of impairment losses and valuation losses resulting from declines in the share prices of securities held. - FY2020MaterialisedAnnual report
「During the consolidated fiscal year, the company recognized impairment losses of ¥205,842 thousand on securities, all of which related to other securities.」
The risk of declines in the value of securities held materialized during the consolidated fiscal year in the form of a ¥205,842 thousand impairment loss on investment securities. - FY2020-Q3RestatedAnnual report
「During the nine-month period ended 31 December, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The company has reaffirmed that there have been no material changes regarding the risk of impairment losses and valuation losses resulting from declines in the share prices of securities held. - FY2020-Q2RestatedAnnual report
「No new business or other risks arose during the first six months of the fiscal year, and there were no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The company has reaffirmed that there have been no material changes regarding the risk of impairment losses and valuation losses resulting from declines in the share prices of securities held. - FY2020-Q1RestatedAnnual report
「No new business or other risks arose during the first three months of the fiscal year, and there were no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The company has reaffirmed that there have been no material changes from the previous fiscal year regarding the risk of impairment losses and valuation losses resulting from declines in the share prices of securities held. - FY2019RestatedAnnual report
「Our group holds both listed and unlisted shares. If a broad and significant decline occurs, impairment losses or valuation losses may arise on securities held, potentially affecting our group's business performance.」
The company has repeated the disclosure of the risk of impairment losses and valuation losses resulting from declines in the share prices of securities held. - FY2019-Q3MaterialisedAnnual report
「Net income attributable to owners of the parent was ¥95 million, down ¥326 million, or 77.3%, from the same quarter of the previous year, partly because an impairment loss on investment securities of ¥190 million was recorded as an extraordinary loss.」
The impairment loss risk on securities held, which had previously been disclosed as a risk, materialized in the form of a ¥190 million impairment loss on investment securities. - FY2019-Q2RestatedAnnual report
「No new business or other risks arose during the first six months of the fiscal year, and there were no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The company has reaffirmed that there have been no material changes from the previous fiscal year regarding the risk of impairment losses and valuation losses resulting from declines in the share prices of securities held. - FY2018RestatedAnnual report
「Our group holds both listed and unlisted shares. If a broad and significant decline occurs, impairment losses or valuation losses may arise on securities held, potentially affecting our group's business performance.」
The company has repeated the disclosure of the risk of impairment losses and valuation losses resulting from declines in the share prices of securities held. - FY2018-Q3RestatedAnnual report
「During the nine-month period ended 31 December, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The company has reaffirmed that there have been no material changes from the previous fiscal year regarding the risk of impairment losses and valuation losses resulting from declines in the share prices of securities held. - FY2017RestatedAnnual report
「Our group holds both listed and unlisted shares. If a broad and significant decline occurs, impairment losses or valuation losses may arise on securities held, potentially affecting our group's business performance.」
The company has repeated the disclosure of the risk of impairment losses and valuation losses resulting from declines in the share prices of securities held. - FY2017-Q3RestatedAnnual report
「During the nine-month period ended 31 December, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The disclosure states that there have been no material changes from the previous fiscal year regarding the risk of declines in the share prices of securities held and impairment losses. - FY2017-Q2RestatedAnnual report
「No new business or other risks arose during the first six months of the fiscal year, and there were no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The disclosure states that there have been no material changes from the previous fiscal year regarding the risk of declines in the share prices of securities held and impairment losses. - FY2016First statedAnnual report
「Our group holds both listed and unlisted shares. If a broad and significant decline occurs, impairment losses or valuation losses may arise on securities held, potentially affecting our group's business performance.」
Risk of declines in market prices associated with holdings of listed and unlisted shares.